| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2018 | Apr 3, 2018 | Oruka Therapeutics, Inc. | COO | Sell | 42.5 | -482 | -3.54% | ✓ | $241.7 |
| Feb 28, 2018 | Mar 1, 2018 | Oruka Therapeutics, Inc. | COO | Sell | 46.3 | -410 | -2.92% | ✓ | $294.4 |
| Apr 4, 2017 | Apr 5, 2017 | Oruka Therapeutics, Inc. | COO | Sell | 46.3 | -390 | -2.70% | ✓ | $939.9 |
| Feb 28, 2017 | Mar 1, 2017 | Oruka Therapeutics, Inc. | COO | Sell | 42.5 | -465 | -3.12% | ✓ | $1.2K |
| Oct 18, 2016 | Oct 18, 2016 | Oruka Therapeutics, Inc. | COO | Sell | 42.5 | -483 | -3.14% | ✓ | $1.2K |
| Sep 20, 2016 | Sep 21, 2016 | Oruka Therapeutics, Inc. | COO | Sell | 42.5 | -714 | -4.44% | ✓ | $2.1K |
| Apr 5, 2016 | Apr 6, 2016 | Oruka Therapeutics, Inc. | COO | Sell | 46.3 | -384 | -2.33% | ✓ | $1.4K |
| Mar 1, 2016 | Mar 2, 2016 | Oruka Therapeutics, Inc. | COO | Sell | 46.3 | -457 | -2.70% | ✓ | $1.6K |
| Oct 16, 2015 | Oct 19, 2015 | Oruka Therapeutics, Inc. | COO | Sell | 46.3 | -496 | -2.85% | ✓ | $2.5K |
| Sep 18, 2015 | Sep 21, 2015 | Oruka Therapeutics, Inc. | COO | Sell | 42.5 | -680 | -3.76% | ✓ | $4.3K |